Proceeds Purposes Dan Rippy, President and CEO of Allegro Diagnostics said, “The Series A financing will enable us to take our first product, based on intellectual property developed at the Boston University School of Medicine, into the clinic to provide earlier, more accurate diagnosis of suspected lung cancer for patients and their doctors.”
M&A Terms
Venture Investor Kodiak Venture Partners
Venture Investor Catalyst Health & Technology Partners
